$20,000 of PHREESIA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Lobbying related to patient reported quality measurement Lobbying related to patient reported quality measurement"
You can find more data on corporate lobbying on Quiver Quantitative.
PHR Insider Trading Activity
PHR insiders have traded $PHR stock on the open market 95 times in the past 6 months. Of those trades, 0 have been purchases and 95 have been sales.
Here’s a breakdown of recent trading of $PHR stock by insiders over the last 6 months:
- EVAN ROBERTS (Chief Operating Officer) has made 0 purchases and 16 sales selling 95,486 shares for an estimated $2,552,473.
- CHAIM INDIG (Chief Executive Officer) has made 0 purchases and 8 sales selling 71,561 shares for an estimated $1,892,464.
- BALAJI GANDHI (Chief Financial Officer) has made 0 purchases and 13 sales selling 64,922 shares for an estimated $1,845,297.
- DAVID LINETSKY (SVP, Life Sciences) has made 0 purchases and 20 sales selling 63,049 shares for an estimated $1,688,120.
- ALLISON C HOFFMAN (General Counsel & Secretary) has made 0 purchases and 14 sales selling 52,203 shares for an estimated $1,374,850.
- MICHAEL WEINTRAUB has made 0 purchases and 4 sales selling 55,152 shares for an estimated $1,321,348.
- AMY BETH VANDUYN (SVP, Human Resources) has made 0 purchases and 9 sales selling 37,876 shares for an estimated $861,673.
- YVONNE HUI (Principal Accounting Officer) has made 0 purchases and 11 sales selling 9,440 shares for an estimated $219,514.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PHR Hedge Fund Activity
We have seen 89 institutional investors add shares of PHR stock to their portfolio, and 89 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TIMESSQUARE CAPITAL MANAGEMENT, LLC removed 868,409 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $21,849,170
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 734,249 shares (-45.1%) from their portfolio in Q4 2024, for an estimated $18,473,704
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) added 727,384 shares (+133.6%) to their portfolio in Q4 2024, for an estimated $18,300,981
- GREENHOUSE FUNDS LLLP added 626,579 shares (+27.9%) to their portfolio in Q4 2024, for an estimated $15,764,727
- FMR LLC removed 544,669 shares (-8.1%) from their portfolio in Q4 2024, for an estimated $13,703,872
- BLAIR WILLIAM & CO/IL removed 534,524 shares (-78.6%) from their portfolio in Q4 2024, for an estimated $13,448,623
- PARK WEST ASSET MANAGEMENT LLC added 423,570 shares (+inf%) to their portfolio in Q4 2024, for an estimated $10,657,021
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PHR Analyst Ratings
Wall Street analysts have issued reports on $PHR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/10/2025
- KeyBanc issued a "Overweight" rating on 01/08/2025
To track analyst ratings and price targets for PHR, check out Quiver Quantitative's $PHR forecast page.
PHR Price Targets
Multiple analysts have issued price targets for $PHR recently. We have seen 2 analysts offer price targets for $PHR in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Joe Vruwink from Robert W. Baird set a target price of $30.0 on 12/11/2024
- Gil Luria from D.A. Davidson set a target price of $32.0 on 11/29/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
